Aprea Therapeutics, Inc. (APRE) vs InMed Pharmaceuticals Inc. (INM)
A side-by-side comparison of Aprea Therapeutics, Inc. and InMed Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
APRE
Aprea Therapeutics, Inc.
$0.67HealthcareDelayed quote: Oct 6, 2026, 10:11 AM EDT
INM
InMed Pharmaceuticals Inc.
$1.33HealthcareDelayed quote: Oct 6, 2026, 10:14 AM EDT
Total return — APRE vs INM
growth of $100 · dividends reinvested · last 7yAPRE -99.8% (-60.0%/yr)INM -100.0% (-67.5%/yr)APRE compounded faster over this window
APRE INM
APRE vs INM: by the numbers
- •APRE is the larger company ($8M vs $7M market cap).
- •Both run net losses; APRE's is the smaller (0.00% vs -0.61% net margin).
Metrics side by side
Valuation
| Metric | APRE | INM |
|---|---|---|
| P/S ratio | N/A | 0.00 |
| P/B ratio | 0.22 | 6.80 |
Profitability
| Metric | APRE | INM |
|---|---|---|
| Gross margin | 0.00% | 14.92% |
| Operating margin | 0.00% | -0.52% |
| Net margin | 0.00% | -0.61% |
| ROE | -31.99% | -1168.44% |
| ROIC | -33.73% | -995.44% |
Growth (annualized)
| Metric | APRE | INM |
|---|---|---|
| Total return CAGR (5Y) | -63.30% | -71.98% |
Frequently asked
- How have APRE and INM total returns compared?
- Over the past 5 years, APRE delivered -63.30% and INM delivered -71.98% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.